240 related articles for article (PubMed ID: 9359695)
1. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice.
Deconinck N; Tinsley J; De Backer F; Fisher R; Kahn D; Phelps S; Davies K; Gillis JM
Nat Med; 1997 Nov; 3(11):1216-21. PubMed ID: 9359695
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
3. [Utrophin, a way to cure Duchenne muscle dystrophy].
Gillis JM
Med Sci (Paris); 2004 Apr; 20(4):442-7. PubMed ID: 15124117
[TBL] [Abstract][Full Text] [Related]
4. Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
Tinsley J; Deconinck N; Fisher R; Kahn D; Phelps S; Gillis JM; Davies K
Nat Med; 1998 Dec; 4(12):1441-4. PubMed ID: 9846586
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.
Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE
Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295
[TBL] [Abstract][Full Text] [Related]
6. Multivariate evaluation of the functional recovery obtained by the overexpression of utrophin in skeletal muscles of the mdx mouse.
Gillis JM
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S90-4. PubMed ID: 12206802
[TBL] [Abstract][Full Text] [Related]
7. Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse.
Deconinck N; Rafael JA; Beckers-Bleukx G; Kahn D; Deconinck AE; Davies KE; Gillis JM
Neuromuscul Disord; 1998 Aug; 8(6):362-70. PubMed ID: 9713852
[TBL] [Abstract][Full Text] [Related]
8. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
[TBL] [Abstract][Full Text] [Related]
9. Does utrophin expression in muscles of mdx mice during postnatal development functionally compensate for dystrophin deficiency?
Pons F; Robert A; Marini JF; Léger JJ
J Neurol Sci; 1994 Apr; 122(2):162-70. PubMed ID: 8021701
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.
Tinsley JM; Potter AC; Phelps SR; Fisher R; Trickett JI; Davies KE
Nature; 1996 Nov; 384(6607):349-53. PubMed ID: 8934518
[TBL] [Abstract][Full Text] [Related]
11. Non-toxic ubiquitous over-expression of utrophin in the mdx mouse.
Fisher R; Tinsley JM; Phelps SR; Squire SE; Townsend ER; Martin JE; Davies KE
Neuromuscul Disord; 2001 Nov; 11(8):713-21. PubMed ID: 11595513
[TBL] [Abstract][Full Text] [Related]
12. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
13. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
14. Expression of truncated utrophin improves pH recovery in exercising muscles of dystrophic mdx mice: a 31P NMR study.
Goudemant JF; Deconinck N; Tinsley JM; Demeure R; Robert A; Davies KE; Gillis JM
Neuromuscul Disord; 1998 Aug; 8(6):371-9. PubMed ID: 9713853
[TBL] [Abstract][Full Text] [Related]
15. Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis.
Law DJ; Allen DL; Tidball JG
J Cell Sci; 1994 Jun; 107 ( Pt 6)():1477-83. PubMed ID: 7962191
[TBL] [Abstract][Full Text] [Related]
16. iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin.
Louboutin JP; Rouger K; Tinsley JM; Halldorson J; Wilson JM
Mol Med; 2001 May; 7(5):355-64. PubMed ID: 11474581
[TBL] [Abstract][Full Text] [Related]
17. The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin.
Porter JD; Rafael JA; Ragusa RJ; Brueckner JK; Trickett JI; Davies KE
J Cell Sci; 1998 Jul; 111 ( Pt 13)():1801-11. PubMed ID: 9625743
[TBL] [Abstract][Full Text] [Related]
18. The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
Perkins KJ; Davies KE
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S78-89. PubMed ID: 12206801
[TBL] [Abstract][Full Text] [Related]
19. An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice.
Gillis JM
Acta Neurol Belg; 2000 Sep; 100(3):146-50. PubMed ID: 11098286
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
